Human Health Innovation

Boehringer Ingelheim is clear about its goals. We want to deliver a portfolio of breakthrough medicines that will improve the lives of patients around the word. That starts with innovation.

Latest Articles on Human Health

Research and Development Pipeline

With a pipeline of around 100 clinical and pre-clinical projects, and the potential to deliver up to 15 new medicine approvals by 2025, we continue our track record of long-term innovation-led performance.

Digital innovation: “Our digital pipeline is only growing”

BRASS, a software advancing patient safety

Human Health Innovation

Digital innovation: “Our digital pipeline is only growing”

BRASS, a software advancing patient safety and developed fully in-house, has been sold. This is proof: our digital innovations are in demand.

“Rapid progress towards clinical candidates”

The rise of drug-resistant pathogens is a real threat.

Human Health Innovation

“Rapid progress towards clinical candidates”

Michel Pairet, Member of the Board of Managing Directors, explains why Boehringer Ingelheim expands its commitment to fighting drug resistant infections with a new joint venture.

Drug Discovery Process